These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7709091)
1. In vitro activity of two beta-lactam antibiotics against strains of the Bacteroides fragilis group isolated from humans and from Callithrix penicillata marmosets. Avila-Campos MJ; de Carvalho MA; Veiga-Damasceno CA; Osório-Cisalpino E Rev Latinoam Microbiol; 1994; 36(3):159-62. PubMed ID: 7709091 [TBL] [Abstract][Full Text] [Related]
2. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)]. Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501 [TBL] [Abstract][Full Text] [Related]
3. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility]. Rodríguez E; Gamboa MM; Rodríguez C; Vargas P Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina. Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852 [TBL] [Abstract][Full Text] [Related]
5. [Detection of beta-lactamases in the Bacteroides fragilis group]. Martin C; Dubreuil L; Sedallian A; Romond C Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153 [TBL] [Abstract][Full Text] [Related]
6. Isolation and identification of strains of Bacteroides fragilis group from the digestive tract of Callithrix penicillata marmosets. Avila-Campos MJ; Raymundo NL; Farias LM; Silva SL; Carvalho MA; Damasceno CA; Pereira LH; Cisalpino EO Lab Anim; 1990 Jan; 24(1):68-70. PubMed ID: 2106054 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group. Bremmelgaard A; Jansen JE; Justesen T; Gottschau A APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792 [TBL] [Abstract][Full Text] [Related]
8. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group]. Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878 [TBL] [Abstract][Full Text] [Related]
9. In vitro antibiotic susceptibility of Bacteroides fragilis strains isolated from excised appendix of patients with phlegmonous or gangrenous appendicitis. Wójcik-Stojek B; Bulanda M; Martirosian G; Heczko P; Meisel-Mikołajczyk F Acta Microbiol Pol; 2000; 49(2):171-5. PubMed ID: 11093680 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Bandoh K; Ueno K; Watanabe K; Kato N Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152 [TBL] [Abstract][Full Text] [Related]
11. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains. Betriu C; Sánchez A; Palau ML; Gómez M; Picazo JJ Antimicrob Agents Chemother; 2001 Aug; 45(8):2372-4. PubMed ID: 11451700 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics. Heseltine PN; Appleman MD; Leedom JM Rev Infect Dis; 1984; 6 Suppl 1():S254-9. PubMed ID: 6585882 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates]. Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024 [TBL] [Abstract][Full Text] [Related]
14. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents. Aldridge KE; Henderberg A; Sanders CV J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group. Snydman DR; Jacobus NV; McDermott LA J Antimicrob Chemother; 2005 Jun; 55(6):1024-8. PubMed ID: 15824092 [TBL] [Abstract][Full Text] [Related]
17. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189 [TBL] [Abstract][Full Text] [Related]
18. Selection of cefoxitin-resistant bacteroides thetaiotaomicron mutants and mechanisms involved in beta-lactam resistance. Fang H; Edlund C; Nord CE; Hedberg M Clin Infect Dis; 2002 Sep; 35(Suppl 1):S47-53. PubMed ID: 12173108 [TBL] [Abstract][Full Text] [Related]
19. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem. Eley A; Greenwood D J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198 [TBL] [Abstract][Full Text] [Related]
20. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains. Nagy E; Szóke I; Gacs M; Csiszár K Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]